Market closed

Elanco/$ELAN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Elanco

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Ticker

$ELAN

Trading on

NYSE

Industry

Pharmaceuticals

Employees

9,550

Elanco Metrics

BasicAdvanced
$7.1B
Market cap
34.58
P/E ratio
$0.41
EPS
1.42
Beta
-
Dividend rate
$7.1B
1.42
$18.80
$10.42
4.3M
2.548
1.055
66.12
66.794
1.02%
1.18%
3.24%
34.583
1.582
1.08
-3.34
18.937
1.99%
-117.72%
-2.40%
-33.98%

What the Analysts think about Elanco

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Elanco stock.

Elanco Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Elanco Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ELAN

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Elanco stock?

Elanco (ELAN) has a market cap of $7.1B as of November 13, 2024.

What is the P/E ratio for Elanco stock?

The price to earnings (P/E) ratio for Elanco (ELAN) stock is 34.58 as of November 13, 2024.

Does Elanco stock pay dividends?

No, Elanco (ELAN) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next Elanco dividend payment date?

Elanco (ELAN) stock does not pay dividends to its shareholders.

What is the beta indicator for Elanco?

Elanco (ELAN) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.